Wednesday, May 18, 2016

U.S. FDA approves Roche's immunotherapy for bladder cancer

May 18 (Reuters) - The U.S. Food and Drug Administration on

Wednesday approved Roche Holding AG's immunotherapy for

the most common form of bladder cancer.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)